Stable Istotope Labelled Vedolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade

Reference: PX-TA1212-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade
SourceCAS 943609-66-3
SpeciesHumanized
Expression systemMammalian cells
Molecular weight147kDa
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsLDP-02,LDP02,MLN-02,MLN0002,MLN02
ReferencePX-TA1212-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-ITGA4_ITGB7(Homo sapiens) (Vedolizumab) Monoclonal Antibody

Vedolizumab is a recombinant humanized monoclonal antibody of isotype IgG1 raised against human lymphocyte ?4?7 integrin, a key mediator of gastrointestinal inflammation. It is used for the treatment of active ulcerative colitis and Crohn’s disease. Vedolizumab can reduce intestinal inflammation by blocking its main target ?4?7 integrin.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Vedolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below